|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.99 USD | -1.86% |
|
-2.39% | -17.39% |
| Jul. 17 | RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276 | MT |
| Jul. 15 | Mizuho Adjusts Price Target on ResMed to $220 From $235, Maintains Outperform Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 249.4 | +25.33% | 15 | |||||||
| 591.27 | +11.04% | 26 | |||||||
| 242.52 | +18.98% | 23 | |||||||
| 504.15 | +45.95% | 29 | |||||||
| 72.43 | +64.5% | 28 | |||||||
| 99 | +15.48% | 25 | |||||||
| 45.65 | +29.98% | 20 | |||||||
| 159.32 | +21.19% | 19 | |||||||
| 413.12 | +11.96% | 24 | |||||||
| 79.33 | +25.79% | 18 | |||||||
| 169.47 | -9.2% | 19 | |||||||
| 234.43 | +56.88% | 18 | |||||||
| 27.95 | +18.13% | 20 | |||||||
| 117.13 | +6.34% | 15 | |||||||
| 1,913.08 | +7.99% | 13 | |||||||
| 59.75 | +2.61% | 12 | |||||||
| 11.63 | +62.02% | 3 | |||||||
| 99.44 | +4.22% | 9 | |||||||
| Average | 282.73 | +23.29% | 19 | ||||||
| Weighted average by Cap. | 333.47 | +24.83% | 23 |
- Stock Market
- Stocks
- RMD Stock
- Sector ResMed, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















